The effect of particular active substances of hallucinogenic mushrooms

Marek Wieczorek

doi:10.2478/fobio-2014-0014

Authors

Marek Wieczorek University of Lodz, Faculty of Biology and Environmental Protection, Department of Neurobiology, Lodz, Poland

DOI:

https://doi.org/10.2478/fobio-2014-0014

Keywords:

magic mushrooms, psilocin, psilocybin, ibotenic acid, muscimol

Abstract

Magic mushrooms have accompanied man for thousands of years. Formerly they were used for religious and culture purposes. Those fungi belong mainly to the genera Conocybe, Copelandia, Panaeolus, Psilocybe and Stropharia. A number of these fungal species produce substances, like psilocybin, psilocin, ibotenic acid or muscimol. Because of their chemical similarity to naturally occurring neurotransmitters like serotonin and GABA these substances, after ingestion, affect brain neurochemistry and by this induce hallucinations. This mini review presents the influence of psilocybin, psilocin, ibotenic acid and muscimol on the nervous system. Also the effects of the above mentioned substances on emotion and mental health of people are discussed.

Downloads

Download data is not yet available.

References

Aghajanian, G.K. & Marek, G.J. 1999. Serotonin and hallucinogens. Neuropsychopharmacology, 21: 16S–23S.
Google Scholar

Carter, O.L., Pettigrew, J.D., Hasler, F., Wallis, G.M., Liu, G.B., Hell, D. & Vollenweider, F.X. 2005. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Neuropsychopharmacology, 30: 1154–1162.
Google Scholar

Delgado, P.L. & Moreno, F.A. 1998. Hallucinogens, serotonin and obsessive-compulsive disorder. J Psychoactive Drugs, 30: 359–366.
Google Scholar

Gonzalez-Maeso, J. & Sealfon, S.C. 2009. Psychedelics and schizophrenia. Trends Neurosci, 32: 225–232.
Google Scholar

Halpern, J.H. 2004. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther, 102: 131–138.
Google Scholar

Hopf, A. & Eckert, H. 1974. Distribution patterns of 14-C-psilocin in the brains of various animals. Act Nerv Super (Praha), 16: 64–66.
Google Scholar

Hyde, C., Glancy, G., Omerod, P., Hall, D. & Taylor, G.S. 1978. Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Br J Psychiatry, 132: 602–604.
Google Scholar

Ikeda, A., Sekiguchi, K., Fujita, K., Yamadera, H. & Koga, Y. 2005. 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. Am J Psychiatry, 162: 815.
Google Scholar

McDonald, A. 1980. Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications. Can J Psychiatry. 25: 586–594.
Google Scholar

Meyer, J.S. & Quenzer, L.F. 2005. Psychopharmacology. Drugs, the Brain, and Behavior. Sinauer Associates, Inc. Sunderland, Massachusetts, USA.
Google Scholar

Muller, K., Puschel, K. & Iwersen-Bergmann, S. 2013. Suicide under the influence of "magic mushrooms". Arch Kriminol, 231: 193–198.
Google Scholar

Passie, T., Seifert, J., Schneider, U. & Emrich, H.M., 2002. The pharmacology of psilocybin. Addict Biol, 7, 357–364.
Google Scholar

Satora, L., Goszcz, H. & Ciszowski, K. 2005. Poisonings resulting from the ingestion of magic mushrooms in Krakow. Przegl Lek, 62, 394–396.
Google Scholar

Stebelska, K. 2013. Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities. Ther Drug Monit, 35: 420–442.
Google Scholar

Tsujikawa, K., Mohri, H., Kuwayama, K., Miyaguchi, H., Iwata, Y., Gohda, A., Fukushima, S., Inoue, H. & Kishi, T. 2006. Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int. 164: 172–178.
Google Scholar